Frequency of the thermolabile variant C677T in the MTHFR gene and lack of association with neural tube defects in the State of Yucatan, Mexico

Clinical Genetics

Volumn 62, Issue 5, 2002, Pages 394-398

  González Herrera, Lizbeth ^a,b   Garcia Escalante G ^a   Castillo Zapata, I ^a   Canto Herrera, J ^a   Ceballos Quintal, J ^a   Pinto Escalante, D ^a   Diaz Rubio F ^b   Del Angel, R M ^c   Orozco Orozco, L ^d  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^b Hospital General O'Horan   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

C677T variant; Genotypic and allelic frequencies; MTHFR; Neural tube defects; Yucatan

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA; RESTRICTION ENDONUCLEASE;

ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MEXICO; NEURAL TUBE DEFECT; NEWBORN; PREVALENCE; PRIORITY JOURNAL; RESTRICTION MAPPING; RISK FACTOR; SPINA BIFIDA; STATISTICAL SIGNIFICANCE;

FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT, NEWBORN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MEXICO; NEURAL TUBE DEFECTS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PREGNANCY;

EID: 0344211885     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.620507.x     Document Type: Article

References (30)

1. Rodríguez M, Guerrero JF, Parra M, Segura MJ, Levario M, Sotelo EI. Folic acid deficiency and its relationship with neural tube defects in northern Mexíco (Mexico). Salud Pública México 1998: 40: 474-480.
2. International Centre for Birth Defects. EUROCAT. World atlas of birth defects. Geneva, Switzerland: World Health Organization 1998, pp. 20.
3. Barber A, Lammer EJ, Shaw G, Greer K, Finnell R. The role of folate transport and metabolism in neural tube defect risk. Mol Genet Metab 1999: 66: 1-9.
4. MCR Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991: 338: 131-137.
5. Whitehead AS, Gallagher P, Mills JL et al. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995: 88: 763-766.
6. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995: 346: 1070-1071.
7. Ou CY, Stevenson RE, Brown VK et al. 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996: 63: 610-614.
8. Shields DC, Kirke PN, Mills JL et al. The 'Thermolabile' variant of Methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 1999: 64: 1045-1055.
9. Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E. Association of the 677-CT mutation on the methylenetetrahydrofolate reductase gene in Turkish patients with neural tube defects. J Child Neurol 1999: 14: 159-161.
10. Mornet E, Muller F, Lenvoisé-Furet A et al. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 1997: 100: 512-514.
11. Koch MC, Stegman K, Ziegler A, Schroter B, Ermert A. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 1998: 157: 487-492.
12. Botto LD, Yang Q. 5,10 Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a Huge Review. Am J Epidemiol 2000: 151: 862-877.
13. Martínez de Villarreal L, Delgado-Enciso I, Váldez-Leal R et al. Folate levels and N5,N1O-Methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study. Arch Medical Res 2001: 32: 277-282.
14. Davalos IP, Olivares N, Castillo MT et al. The C677T polymorphism of the methylenetetrahydrofolate reductase gene in Mexican mestizo neural-tube defect parents, control mestizo and native populations. Ann Génét 2000: 43: 89-92.
15. Mutchinik OM, López Luna MA, Waxman L, Babinsky J, Ryvemce Collaborative Group VE. High prevalence of the thermolabile Methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metab 1999: 68: 461-467.
16. Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995: 10: 111-113.
17. Barber R, Shalat S, Hendrincks K et al. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas Hispanic population. Mol Genet Metab 2000: 70: 45-52.
18. Volcik K, Blanton Tyerman S et al. Methyelenetetrahydrofolate reductase and spina bifida: Evaluation of level of defect and maternal genotypic risk in Hispanics. Am J Med Genet 2000: 95: 21-27.
19. Shaw GM, Rozen R, Finnell RH, Wasserman C, Lammer E. Maternal vitamin use, genetic variation of infant methylentetrahydrofolate reductase, and risk for spina bífida. Am J Epidemiol 1998: 148: 30-37.
20. Nelen WL, Steegers EA, Eskes TK, Blom HJ. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet 1997: 350: 861.
21. Isotalo PA, Wells GA, Donelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: An examination of C677T and A1298C mutations. Am J Hum Genet 2000: 67: 986-990.
22. Volcik KA, Blanton SH, Northrup H. Examinations of Methylenetetrahydrofolate reductase C677T and A1298C mutations - and in utero viability. Am J Hum Genet 2001: 69: 1150-1152.
23. Botto LD, Moore CA, Khoury MJ, Erickson D. Medical progress: Neural tube defects. N Engl J Med 1999: 341: 1509-1519.
24. Papapetrou C, Lynch SA, Burn J, Edwards YH. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 1996: 348: 58.
25. Molloy A, Daly S, Mills J et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 1997: 349: 1591-1593.
26. Speer M, Nye J, McLone D et al. Possible interaction of genotypes at cystathionine beta-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects. NTD Collaborative Group. Clin Genet 1999: 6: 142-144.
27. Botto LD, Mastroiacovo P. Exploring gene-gene interactions in the etiology of neural tube defects. Clin Genet 1998: 53: 456-459.
28. van der Put M, Gabreëls F, Stevens EM et al. A second common mutation in the methylenentetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am J Hum Genet 1998: 62: 1044-1051.
29. Cerda-Flores R, Villalobos-Torres M, Barrera-Saldaña H et al. Genetic admixture in three Mexican Mestizo populations based on D1S80 and HLA-DQA1 loci. Am J Hum Biol 2002: 14: 257-263.
30. Engbersen A, Franken D, Boers G, Stevens E, Trijbels F, Blom H. Thermolabile 5, 10-Methylenetetrahydrofolate reductase as a cause of mild hyperhomocisteinemia. Am J Hum Genet 1995: 56: 142-150.